Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease

NCT01474369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

827

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-erosive Gastroesophageal Reflux Disease

Interventions

DRUG: TAK-438
DRUG: TAK-438
DRUG: Placebo

Sponsor

Takeda